Atlas Trials

Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight

Clinical trial NCT02958085 · COMPLETED

Trial details

NCT number
NCT02958085
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metabolism and Nutrition DisorderObesity
Start date
2016-11-04
Primary completion
2018-01-24
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.